Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals
出版年份 2020 全文链接
标题
Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 3, Pages 604
出版商
MDPI AG
发表日期
2020-01-31
DOI
10.3390/molecules25030604
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma
- (2019) Zhilan Chai et al. ACS Nano
- Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
- (2018) Fwu-Long Mi et al. ACS Biomaterials-Science & Engineering
- Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
- (2018) Fwu-Long Mi et al. ACS Biomaterials Science & Engineering
- RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
- (2018) Zhi-gang Huang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
- (2017) Min Chen et al. International Journal of Nanomedicine
- Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer
- (2017) Thomas Powles et al. JOURNAL OF CLINICAL ONCOLOGY
- Albumin-coated nanocrystals for carrier-free delivery of paclitaxel
- (2017) Joonyoung Park et al. JOURNAL OF CONTROLLED RELEASE
- Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores
- (2017) Wei Gao et al. JOURNAL OF CONTROLLED RELEASE
- Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer
- (2016) Aaron Goldman et al. ACS Nano
- Impact of surfactant treatment of paclitaxel nanocrystals on biodistribution and tumor accumulation in tumor-bearing mice
- (2016) Wei Gao et al. JOURNAL OF CONTROLLED RELEASE
- Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
- (2015) Sylvie Lorenzen et al. EUROPEAN JOURNAL OF CANCER
- A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel
- (2015) Hongxiang Hu et al. JOURNAL OF CONTROLLED RELEASE
- A Novel Combined Micellar System of Lapatinib and Paclitaxel with Enhanced Antineoplastic Effect Against Human Epidermal Growth Factor Receptor-2 Positive Breast Tumor In Vitro
- (2015) Yan Wei et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
- (2014) Taroh Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
- (2013) Qi Yin et al. ADVANCED DRUG DELIVERY REVIEWS
- Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
- (2013) Ameya R. Kirtane et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer
- (2013) Zhongzhen Guan et al. JOURNAL OF CLINICAL ONCOLOGY
- Physical and chemical stability of drug nanoparticles
- (2011) Libo Wu et al. ADVANCED DRUG DELIVERY REVIEWS
- State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery
- (2011) Rainer H. Müller et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
- (2011) Daniele Vergara et al. Nanomedicine-Nanotechnology Biology and Medicine
- Paclitaxel- and lapatinib-loaded lipopolymer micelles overcome multidrug resistance in prostate cancer
- (2011) Feng Li et al. Drug Delivery and Translational Research
- A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy
- (2010) Ken Kato et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Combined lapatinib and paclitaxel in HER2-positive breast cancer
- (2009) Carlos A. Castañeda et al. Nature Reviews Clinical Oncology
- Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer
- (2008) Henry L. Gomez et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
- (2008) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now